FlaggedRx← Medication recall checkHome
Class II · ModerateRecall completed

Ropinirole

Could cause temporary or reversible harm; serious harm is unlikely.

Does this affect you?
Check your lot numberLot DJ2744, Exp 12/2014
Where it was soldNationwide
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.

What happened

Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.

What to do

  1. Check the lot number and expiry on your medicine against the recall above.
  2. Talk to your pharmacist or doctor before changing anything — don't stop on your own.
  3. Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).

Who makes it

Distributed by / forSandoz, Inc
NDC0781-5780-92
Show the full FDA record
Full product labelRopinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92
Recalling firmSandoz, Inc
DistributionNationwide
Quantity692 bottles (90 count)
Recall initiated2013-10-09
Report date2013-11-13
Recall completed2014-07-07
Recall numberD-66458-1
ClassificationClass II
FDA statusTerminated
Origin on filePrinceton NJ United States

Related

Recent drug recallsCheck another medication

Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗

This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.